相关实验视频
Updated: May 24, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.2K
用于帕金森病的设备辅助疗法
Nadia Mouchaileh1,2, Jillian Cameron1,2
1Austin Health, Melbourne.
Australian prescriber
|March 5, 2025
概括
设备辅助疗法,如输液和深度大脑刺激,可以管理高级帕金森病症状. 选择正确的治疗方法需要专家咨询和多学科的护理.
科学领域:
- 神经学 神经学
- 医疗器械 医疗器械
背景情况:
- 晚期帕金森病通常表现为运动波动和动力障碍.
- 口服和透皮治疗可能在晚期疾病阶段不足以控制症状.
研究的目的:
- 审查高级帕金森病的设备辅助疗法.
- 概述不同疗法的作用及其管理.
主要方法:
- 设备辅助疗法的审查,包括皮下阿波莫尔芬输注,肠道莱沃多巴输注,皮下莱沃多巴输注和深度大脑刺激.
- 讨论影响治疗选择和管理方案的因素.
主要成果:
- 设备辅助疗法为管理运动波动和运动障碍提供了选择.
- 皮下注射比肠道注射或深度大脑刺激更少侵入性.
- 治疗选择是个性化的,基于患者的因素.
结论:
- 设备辅助疗法对于高级帕金森病管理至关重要.
- 专家的多学科参与对于启动和管理至关重要.
- 初级保健在持续的患者支持和不良事件监测中起着至关重要的作用.
关键词:
帕金森病是帕金森病的一种疾病.亚博体育app 亚博体育app 亚博体育app 亚博体育app深度大脑刺激 刺激大脑设备辅助疗法 设备辅助疗法肠道输液是一种肠道输液.利沃多帕 (levodopa) 是一种可以使用的药物.皮下注射是用皮下注射的方式.更多相关视频
14:56The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
Published on: September 23, 2018
9.0K
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.2K
相关概念视频
01:24Parkinson's Disease: Treatment
182
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
182
01:15Parkinson's Disease: Overview
419
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
419